1Higashihara E,Nutahara K,Kojima M,et al.Significance of serum free prostate specific antigen in the screening of prostate cancer[J].J Urol,1996,156(6):1964-1968.
3Christensson A,Bjork T,Nilsson O,et al.Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer[J].J Urol,1993,150(1):100-105.
6Kort SA,Martens F,Vanpoucke H,et al.Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation[J].Clin Chem,2006,52(8):1568-1574.
二级参考文献11
1Benson MC, Whang TS, Classon CA, et al. The use of prostate spectific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen [J] . J Uol, 1992, 147:817
2Lujan M, Paez A, Lanes L, et al. Proste specific antigen density is there a role for this paramter when screening forprostate cancer[J]. Prost Cancer, Prost Dis, 2001, 4:146
3Morote J, Raventos CX, Lorente JA, et al. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal e
3Committee National for Clinical Laboratory Standards.EP9-A Method comparison and bias estimation using patient samples[S].Wayne,PA:NCCLS.1995.
4U.S.Department of Health and Human Services.Medicare,medicaid and CLIA program:regulations implementing the clinical laboratory improvement amendments of 1988(CLIA)final rule[S].Fed Regist,1992,57:7002-7186.
5Christensson A, Bjork T, Nilsson O, et al. Serum prostate specific anti- gen complexed to alpha antichymotrypsin as an indicator of prostate cancer[J]. J Urol, 1993, 150(1) :100 -105.
